A wearable spatiotemporal controllable ultrasonic device with amyloid-β disaggregation for continuous Alzheimer’s disease therapy
Science Advances · 2025-08 · 11 (31)
DOI: 10.1126/sciadv.adw1732 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025-08. Verfasst von Faxing Zou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Advanced Study (IAS), Shenzhen University, Shenzhen, Guangdong 518060, People's Republic of China. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Wearable Electronic Devices, Ultrasonic Therapy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Demenz
Abstract (Originalsprache)
The rising prevalence of Alzheimer’s disease (AD) due to an aging population has made the search for effective treatments more urgent than ever. Previous studies have demonstrated that continuous ultrasound can depolymerize amyloid proteins, offering potential relief from AD. In this study, we present a portable, fully integrated wearable ultrasound system designed to promote amyloid protein depolymerization. The system comprises a flexible honeycomb ultrasonic array patch, a flexible printed circuit, and an interactive terminal control system to facilitate the treatment process. Our results demonstrate that the system effectively reduces amyloid proteins in the brain, improves cognitive function in a familial Alzheimer’s disease (FAD) mouse model, enhances microglial phagocytosis of amyloid-β plaques, and shifts microglia polarization from M1 to M2. These changes contribute to a mitigated inflammatory environment in the brain. This innovative approach may pave the way for noninvasive, personalized treatments for AD, potentially transforming therapeutic strategies in neurodegenerative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Advanced Study (IAS), Shenzhen University, Shenzhen, Guangdong 518060, People's Republic of China.
- Longgang Central Hospital of Shenzhen, Shenzhen 518116, People's Republic of China.
ORCID-Profile: Faxing Zou, Yibiao Liu, Yong Luo, Tailin Xu
Zitieren
APA
Zou, F., Liu, Y., Luo, Y., & Xu, T. (2025). A wearable spatiotemporal controllable ultrasonic device with amyloid-β disaggregation for continuous Alzheimer’s disease therapy. Science Advances, 11(31). https://doi.org/10.1126/sciadv.adw1732
Vancouver
Zou F, Liu Y, Luo Y, Xu T. A wearable spatiotemporal controllable ultrasonic device with amyloid-β disaggregation for continuous Alzheimer’s disease therapy. Science Advances. 2025;11(31). doi:10.1126/sciadv.adw1732
BibTeX
@article{Zou2025,
author = {Zou, Faxing and Liu, Yibiao and Luo, Yong and Xu, Tailin},
title = {A wearable spatiotemporal controllable ultrasonic device with amyloid-β disaggregation for continuous Alzheimer’s disease therapy},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {31},
doi = {10.1126/sciadv.adw1732}
}
EUVIMED